|
|
|
RESEARCH PAPER
Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100083, China
SRCs (steroid receptor coactivators) are required for nuclear receptor-mediated transcription and are also implicated in the transcription initiation by other transcription factors, such as STATs and NF
B. Despite phenotypic manifestations in gene knockout mice for SRC-1, GRIP1, and AIB1 of the SRC (Steroid Receptor Coactivator) family indicating their differential roles in animal physiology, there is no clear evidence, at the molecular level, to support a functional specificity for these proteins. We demonstrated in this report that two species of SRC coactivators, either as AIB1:GRIP1 or as AIB1:SRC-1 are recruited, possibly through heterodimerization, on the promoter of genes that contain a classical hormone responsive element (HRE). In contrast, on non-HRE-containing gene promoters, on which steroid receptors bind indirectly, either GRIP1 or SRC-1 is recruited as a monomer, depending on the cellular abundance of the protein. Typically, non-HRE-containing genes are early genes activated by steroid receptors, whereas HRE-containing genes are activated later. Our results also showed that SRC proteins contribute to the temporal regulation of gene transcription. In addition, our experiments revealed a positive correlation between AIB1/c-myc overexpression in ER+ breast carcinoma samples, suggesting a possible mechanism for AIB1 in breast cancer carcinogenesis.
[Keywords: Gene regulation; coactivators; steroid receptors]
Received February 16, 2004; revised version accepted May 21, 2004.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1194704.
1 These authors contributed equally to this work.
2 Corresponding author.
E-MAIL jason{at}bjmu.edu.cn; FAX 86-10-82801355.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Chen, L. Shi, L. Zhang, R. Li, J. Liang, W. Yu, L. Sun, X. Yang, Y. Wang, Y. Zhang, et al. The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer J. Biol. Chem., June 27, 2008; 283(26): 17969 - 17978. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lodrini, T. Munz, N. Coudevylle, C. Griesinger, S. Becker, and E. Pfitzner p160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain Nucleic Acids Res., April 1, 2008; 36(6): 1847 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fan, Z. Chen, Y. Chen, and Y. Shang Mechanistic Roles of Leptin in Osteogenic Stimulation in Thoracic Ligament Flavum Cells J. Biol. Chem., October 12, 2007; 282(41): 29958 - 29966. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shi, J. Liang, X. Yang, Y. Wang, Y. Zhao, H. Wu, L. Sun, Y. Zhang, Y. Chen, R. Li, et al. Integration of Estrogen and Wnt Signaling Circuits by the Polycomb Group Protein EZH2 in Breast Cancer Cells Mol. Cell. Biol., July 15, 2007; 27(14): 5105 - 5119. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, R.-C. Wu, L. Amazit, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley Specific Amino Acid Residues in the Basic Helix-Loop-Helix Domain of SRC-3 Are Essential for Its Nuclear Localization and Proteasome-Dependent Turnover Mol. Cell. Biol., February 15, 2007; 27(4): 1296 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. B. Wetherill, J. K. Hess-Wilson, C. E.S. Comstock, S. A. Shah, C. R. Buncher, L. Sallans, P. A. Limbach, S. Schwemberger, G. F. Babcock, and K. E. Knudsen Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer Mol. Cancer Ther., December 1, 2006; 5(12): 3181 - 3190. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wu, L. Sun, Y. Zhang, Y. Chen, B. Shi, R. Li, Y. Wang, J. Liang, D. Fan, G. Wu, et al. Coordinated Regulation of AIB1 Transcriptional Activity by Sumoylation and Phosphorylation J. Biol. Chem., August 4, 2006; 281(31): 21848 - 21856. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Waters, B. Yue, V. Veverka, P. Renshaw, J. Bramham, S. Matsuda, T. Frenkiel, G. Kelly, F. Muskett, M. Carr, et al. Structural Diversity in p160/CREB-binding Protein Coactivator Complexes J. Biol. Chem., May 26, 2006; 281(21): 14787 - 14795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Grenier, A. Trousson, A. Chauchereau, J. Cartaud, M. Schumacher, and C. Massaad Differential Recruitment of p160 Coactivators by Glucocorticoid Receptor between Schwann Cells and Astrocytes Mol. Endocrinol., February 1, 2006; 20(2): 254 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kishimoto, Z. Wang, P. Bhat-Nakshatri, D. Chang, R. Clarke, and H. Nakshatri The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1{alpha}/CXCL12 Carcinogenesis, October 1, 2005; 26(10): 1706 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cheung, M. L. Acevedo, P. A. Cole, and W. L. Kraus Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1 PNAS, January 18, 2005; 102(3): 559 - 564. [Abstract] [Full Text] [PDF] |
||||